Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline

Tip Ranks

Apr 3, 2026 at 09:22 PM

Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline

Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline

Login to unlock71characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

Sep 10, 2026 at 08:54 AMAAPL: Memory Costs Surge, Price Hikes Loom — Can Foldables Save the Day?
Aug 31, 2026 at 05:20 PMTrump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
Aug 26, 2026 at 03:08 PMHotter PCE Inflation: 5 Defensive ETFs Investors Can Turn to as Rate-Cut Hopes Fade
Aug 20, 2026 at 12:49 AMMerck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For
Jul 22, 2026 at 01:38 PMTrump Says US To Exempt Import Tariff On Generic Drugs For Two Years

Related Stocks

Kezar Life Sciences

USKZR

0.00%

Aurinia Pharma

USAUPH

-1.72%

SPDR S&P Biotech

USXBI

LongbridgeAI